TSBX - Turnstone Biologics Corp
IEX Last Trade
0.7028
0.009 1.252%
Share volume: 159,361
Last Updated: Fri 30 Aug 2024 10:00:00 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$0.69
0.01
1.27%
View ratios
| Fiscal Date | 2024-03-31 | |
|---|---|---|
| Fiscal Quarter | Q1 2024 | |
| Report Date | 2024-05-13 | |
| Assets | ||
| Total Assets | 94.390 M | |
| Current Assets | 84.981 M | |
| Inventories | 0.000 | |
| Other Current Assets | 7.018 M | |
| Short Term Investments | 7.018 M | |
| Total Receivables | 0.000 | |
| Current Cash | 77.847 M | |
| Total Non-current Assets | 9.409 M | |
| Property Plant Equipment | 5.982 M | |
| Other Assets | 1.115 M | |
| Intangible Assets | 0.000 | |
| Goodwill | 0.000 | |
| Liabilities and shareholders’ equity | ||
| Total Liabilities and shareholders’ equity | 94.390 M | |
| Total liabilities | 14.379 M | |
| Total current liabilities | 12.646 M | |
| Accounts Payable | 1.423 M | |
| Other liabilities | 1.042 M | |
| Current long term debt | 0.000 | |
| Long term debt | 0.000 | |
| Other liabilities | 1.042 M | |
| Minority interest | 0.000 | |
| Total Shareholder equity | 80.011 M | |
| Common stock | 23.012 M | |
| Retained earnings | -196.387 M |